Besides leukemia, overexpression of MYB has also been implicated in the development of other malignancies, such as breast, colon and prostate cancer, adenoid cystic carcinoma (ACC) and low-grade glioma [35,36,37]. This evidence concerns the gene MYB and leukemia.